跳至主要内容
临床试验/IRCT20230407057838N1
IRCT20230407057838N1已完成2 期

Comparison of the therapeutic effect of vaginal bromocriptine and dienogest on ultrasound and bleeding and pain due to adenomyosis

Iran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 50 years(—)
性别
Female

入选标准

  • History of 6 months of painful and regular menstruation

排除标准

  • having a history of specific diseases (including epilepsy, gastrointestinal, cardiovascular, renal disorders) according to the person's own statement.
  • allergies to dienogest and bromocriptine
  • Presence of significant gynecological disease or abdominal and pelvic surgery in the last 6 months
  • - Not using gonadotropin agonist or antagonist, hormonal contraceptive in the last three months.

研究者

相似试验

vaginal bromocriptine and dienogest on the treatment... | 临床试验